Interferon-gamma (IFN-γ) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC)

Clinical and Experimental Immunology

Volumn 117, Issue 3, 1999, Pages 469-475

  Monteleone, G ^a,b   Parrello, T ^a   Monteleone, I ^a   Tammaro, S ^a   Luzza, F ^a   Pallone, F ^a,c,d  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Policlinico Universitario   (Italy)

Author keywords

IL 12; Interferon gamma; Intestinal inflammation; Lipopolysaccharide; Prostaglandin E2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INDOMETACIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LAMINA PROPRIA; MONONUCLEAR CELL; PRIORITY JOURNAL;

CELLS, CULTURED; COLON; DINOPROSTONE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES;

EID: 0032800437     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00991.x     Document Type: Article

References (39)

1. 1 Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-76.
2. 2 Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4006-27.
3. 3 Hendrzak JA, Brunda MJ. Biology of disease. Interleukin-12. Biology activity, therapeutic utility, and role in disease. Lab Invest 1995; 72:619-37.
4. 4 Ma X, Chow JM, Cri G et al. The interleukin 12 p40 gene promoter is primed by interferon-γ in monocytic cells. J Exp Med 1996; 183:147-57.
5. 5 Flesch IEA, Hess JH, Huang S et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumour necrosis factor α. J Exp Med 1995; 181:1615-21.
6. 6 Monteleone G, Biancone L, Marasco R et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112:1169-78.
7. 7 Parronchi P, Romagnani P, Annunziato F et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997; 150:823-32.
8. 8 Pallone F, Fais S, Boirivant M. The Interferon system in inflammatory bowel disease. In: Fiocchi C, eds. Cytokines in inflammatory bowel disease. Austin, Texas: R G Landes Co., 1995:57-67.
9. 9 Fais S, Capobianchi MR, Pallone F et al. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to Interferon gamma inducers. Gut 1991; 32:403-7.
10. 10 Fais S, Capobianchi MR, Silvestri M et al. Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells. J Interferon Res 1994; 14:235-8.
11. 11 Fuss IJ, Neurath M, Boirivant M et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-70.
12. 12 Neurath MF, Fuss I, Kelsall BL et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182:1281-90.
13. 13 Monteleone G, Parrello T, Luzza F et al. Response of human intestinal lamina propría T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7. Gut 1998; 43:620-8.
14. 14 Kuhn R, Lohler J, Rennick D et al. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
15. 15 Sellon RK, Tonkonogy S, Schultz M et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998; 66:5224-31.
16. 16 Portanova JP, Zhang Y, Anderson GD et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996; 184:883-91.
17. 17 Williams TJ, Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 1973; 246:215-7.
18. 18 Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991, 12:349-52.
19. 19 van der Pouw Kraan TCTM, Boeije LCM, Smcenk RJT et al. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995; 181:775-9.
20. 20 Strassmann G, Koota VP, Finkelman F et al. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages hy prostaglandin E2. J Exp Med 1994; 180:2365-70.
21. 21 Scheuer WV, Hobbs MV, Weigle WO. Interference with tolerance induction in vivo by inhibitors of prostaglandin synthesis. Cell Immunol 1987; 104:409-16.
22. 22 Rugtveit J, Nilsen EM, Bakka A et al. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997; 112:1493-505.
23. 23 Nathens AB, Rotstein OD, Dackiw APB et al. Intestinal epithelial cells down-regulate macrophage tumor necrosis factor-alpha secretion: a mechanism for immune homeostasis in the gut-associated lymphoid tissue. Surgery 1995; 118:343-51.
24. 24 Young HA, Hardy KJ. Role of interferon-gamma in immune cell regulation. J Leuk Biol 1995; 58:373-81.
25. 25 Hayes MP, Wang J, Norcross MA. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 1995; 86:646-50.
26. 26 Docke W-D, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration hy IFN-γ treatment. Nature Med 1997; 3:678-81.
27. d (endotoxin resistance) phenotype. J Exp Med 1986; 164:1791-6.
28. 28 D'Andrea A, Ma X, Aste-Amezaga M et al. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor a production. J Exp Med 1995; 181:537-46.
29. 29 Li C, Goodrich JM, Yang X. Interferon-gamma (IFN-γ) regulates production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected monocyte/macrophage lineage. Clin Exp Immunol 1997; 109:421-5.
30. 30 Takasuka N, Tokunaga T, Akagawa KS. Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α mRNA but not of IL-1β mRNA. J Immunol 1991; 146:3824-30.
31. 31 Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989; 83:724-7.
32. 32 Adams RB, Planchon SM, Roche JK. IFN-γ modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 1993; 150:2356-63.
33. 33 Strober W, Kelsall B, Fuss I et al. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol Today 1997; 18:61-64.
34. 34 Duchmann R, Schmitt E, Knolle P et al. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996; 26:934-8.
35. 35 Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991; 146:108-13.
36. 36 Snijdewint FGM, Kalinski P, Wierenga EA et al. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993; 150:5321-9.
37. 37 Stewart TH, Hetenyi C, Rowsell H et al. Ulcerative enterocolitis in dogs induced by drugs. J Pathol 1980; 131:363-78.
38. 38 Bjarnason I, Smethurst P, Levi AJ et al. Indomethacin induced chronic small intestinal ulceration in the rat. Gastroenterology 1988; 94:1937.
39. 39 Rieser C, Papesh C, Herold M et al. Differential deactivation of human dendritic cells by endotoxin desensitisation: role of tumor necrosis factor-α and prostaglandin E2. Blood 1998; 91:3112-7.